European Healthcare Expenditure on Epidemiological Surveillance and Risk and Disease Control Programmes by Country

European healthcare expenditure on epidemiological surveillance and disease control varies significantly by country, with Sweden, Iceland, and Greece leading in spending as a percentage of GDP. In 2023, Sweden saw an 87.22% year-on-year increase, while Iceland rose by 76.23%. Denmark's expenditure increased by 69.52%, and Greece's by 30.26%. Conversely, Germany, Luxembourg, France, and Latvia reported no year-on-year growth. Over five years, variations in spending highlight shifting priorities across Europe.

Looking forward, an expected continuation of fostering collaborative EU-wide regional health strategies is crucial. Keeping an eye on the development of cross-border digital health solutions and personalized surveillance systems for enhanced disease control is essential. Emerging technologies and data analytics could further drive strategic investment enhancements in healthcare surveillance. Furthermore, the potential policy developments and economic responses to future health crises can greatly influence expenditure levels and distributions.